Diagnostic and Statistical Manual of Mental Disorders

Diagnostic and Statistical Manual of Mental Disorders
source
Name	Diagnostic and Statistical Manual of Mental Disorders
Caption	Cover of the manual
Editor	American Psychiatric Association
Country	United States
Language	English
Subject	Psychiatric diagnosis
Publisher	American Psychiatric Association
Pub date	1952–present
Pages	varies

Diagnostic and Statistical Manual of Mental Disorders is a classification of mental disorders published by the American Psychiatric Association. It serves as a reference for clinicians, researchers, insurers, and policy makers in psychiatry, psychology, and allied health fields. The manual has been central to debates involving public health, law, insurance, and biomedical research.

History and editions

The manual originated in the post‑World War II era amid initiatives linked to World Health Organization, National Institute of Mental Health, American Psychiatric Association, Harry Stack Sullivan, and figures associated with wartime psychiatric screening such as William Menninger and Karl Menninger. Early editions responded to needs expressed by entities like United States Department of Defense, Veterans Administration, National Institutes of Health, Cold War era public health planning, and clinical systems developed by clinics such as Menninger Clinic. Major revisions have often reflected influences from committees that included scholars connected to institutions such as Harvard University, Johns Hopkins University, Columbia University, University of California, Los Angeles, and Massachusetts General Hospital. Editions from the first (1952) through the fifth (2013) have intersected with landmark events and publications including work by Sigmund Freud–linked schools, critiques by Thomas Szasz, policy shifts tied to Civil Rights Movement, and later evidence syntheses associated with Cochrane Collaboration style approaches. Contributors have included clinicians and researchers affiliated with Stanford University, Yale University, University of Pennsylvania, New York University, and international advisory participants from World Health Organization collaborations.

Organization and diagnostic criteria

The manual organizes diagnoses into categorical groupings and dimensional specifiers drawn from research traditions at institutions like University College London, University of Oxford, Karolinska Institute, McGill University, and King's College London. Diagnostic entries commonly list criteria influenced by operational definitions developed in contexts such as the Feighner criteria lineage and methodological work connected to Robert Spitzer at Columbia University. Each disorder entry typically includes diagnostic features, associated features, differential diagnosis guidance, prevalence estimates often compared with epidemiological studies by teams at Johns Hopkins University and Harvard Medical School, and coding crosswalks for billing systems like those administered by Centers for Medicare & Medicaid Services and insurers linked to Blue Cross Blue Shield. The manual uses specifiers and severity ratings that echo dimensional models discussed in conferences at American Psychological Association and research from centers at National Institute of Mental Health.

Development and revision process

Revisions have been overseen by task forces and workgroups drawing members from academic centers such as Yale University, University of California, San Diego, University of Toronto, University of Michigan, and international consultants from World Health Organization. Major revision methodologies incorporated field trials coordinated with hospitals like Massachusetts General Hospital and community samples from public health departments in jurisdictions including New York City and Los Angeles County. Controversial procedural choices have been the subject of hearings before bodies like United States Congress committees and critiques in journals associated with publishers such as Elsevier and Wiley-Blackwell. Notable figures in revision history include clinicians and researchers affiliated with Columbia University, Harvard Medical School, and University of Pennsylvania who debated reliability, validity, and utility of criteria.

Contents and classification systems

The manual's contents comprise categories such as neurodevelopmental disorders, psychotic disorders, mood disorders, anxiety and related disorders, and personality disorders, paralleling classification efforts from groups at King's College London, University of Cambridge, Karolinska Institute, and research consortia like the ENIGMA Consortium. Crosswalks to diagnostic coding draw on the International Classification of Diseases maintained by World Health Organization and billing systems used by agencies including Centers for Medicare & Medicaid Services and international health ministries such as NHS England and Health Canada. The manual has incorporated dimensional assessments (severity ratings, symptom scales) influenced by measurement work at University of California, Berkeley and psychometric research from University of Minnesota and Penn State University.

Reception, controversies, and impact

Reception has ranged from adoption in clinical settings at hospitals like Mayo Clinic and academic departments at Harvard Medical School to sustained criticism from figures and organizations such as Thomas Szasz, advocacy groups including National Alliance on Mental Illness, and scholars at Columbia University and University College London. Controversies have involved debates over disease boundaries exemplified by disputes about diagnoses influenced by research teams at Johns Hopkins University, public policy implications scrutinized by legislative bodies like the United States Congress, insurance reimbursement consequences linked to Centers for Medicare & Medicaid Services, and cultural critiques referencing scholars from University of Chicago and London School of Economics. The manual's influence extends to forensic contexts in courts such as those in United States Court of Appeals jurisdictions, educational policy in systems like New York State Education Department, and pharmaceutical trials conducted by companies headquartered in regions including Basel and Cambridge, Massachusetts.

International use and relations with ICD

Although primarily produced by the American Psychiatric Association, the manual is used worldwide alongside the International Classification of Diseases published by World Health Organization. Cross‑national comparisons and harmonization efforts have involved research centers at University of Toronto, University College London, Karolinska Institute, Monash University, and health ministries such as NHS Scotland and Canadian Institutes of Health Research. Tensions between the manual and ICD coding have prompted joint meetings with representatives from World Health Organization, national psychiatric associations including Royal College of Psychiatrists and Canadian Psychiatric Association, and methodological contributions from consortia such as Global Mental Health initiatives.

Category:Psychiatry